Trials / Completed
CompletedNCT05572606
Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol
Development and Delivery of a Novel Hypnotherapy Protocol for Treatment of Symptomatic Bloating
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to evaluate if hypnotherapy delivered electronically will help with bloating symptoms.
Detailed description
This study consists of seven pre-recorded hypnotherapy sessions that will be digitally delivered to patients on their own electronic devices via an existing digital platform provided by metaMe Health. metaMe Health is a company specialized in the delivery of digital hypnotherapy protocols. The sessions will be delivered to patients over twelve weeks in accordance with current gut-direct hypnotherapy practice. The patients must agree to have their consent and content delivered electronically and provide periodic outcomes by completing electronic symptom questionnaires. The whole study will last for 24 weeks: the initial 12-week treatment period and then an additional 12-week follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Hypnotherapy | Seven pre-recorded hypnotherapy sessions delivered over the course of twelve weeks via the patient's own electronic device such as a smartphone, tablet, or laptop. The length of the audio-recorded treatment sessions is expected to be approximately 40 minutes on average. |
Timeline
- Start date
- 2023-01-26
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2022-10-07
- Last updated
- 2025-10-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05572606. Inclusion in this directory is not an endorsement.